During Lewis lung carcinoma (LLC)-induced cachexia, gp130-STAT3 signaling activates p38 MAPK, which in turn stimulates FOXO3 and Atrogin-1 expression, promoting muscle degradation (91, 92). This evidence concerns the gene STAT3 and Cachexia.